Albus Health makes medical devices for nocturnal COPD monitoring. Its main product, Albus Home RD, passively records sleeping breathing and converts it into actionable insights for clinicians, researchers, and patients. It stands out by minimizing patient effort and prioritizing data reliability in sleep and respiratory medicine, supported by biomedical engineering and collaborations with groups like the UCB Digital Health incubator and the AstraZeneca BioVentureHub. The goal is to improve nighttime COPD management through continuous, easy-to-use respiratory monitoring that aids clinical decisions and research, with revenue from device sales and analytics subscriptions.
Company Size
1-10
Company Stage
Early VC
Total Funding
$5.4M
Headquarters
Oxford, United Kingdom
Founded
2017
See people who can refer or advise you